New antimicrobials in the management of cystic fibrosis

Journal of Antimicrobial Chemotherapy

Volumn 49, Issue 2, 2002, Pages 235-238

  Høiby, Niels ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALGINIC ACID; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; AZITHROMYCIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFSULODIN; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; FURANONE DERIVATIVE; IMIPENEM; LYASE; MACROLIDE; PHOSPHOLIPID; PIPERACILLIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIBODY TITER; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; BINDING AFFINITY; BIOFILM; COLONY FORMING UNIT; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME ACTIVITY; GENE MUTATION; GRAM NEGATIVE INFECTION; HUMAN; IMMUNE RESPONSE; LUNG INFECTION; MAINTENANCE THERAPY; MINIMUM INHIBITORY CONCENTRATION; OXYGEN CONCENTRATION; PHENOTYPE; PSEUDOMONAS AERUGINOSA; TISSUE INJURY;

EID: 0036168753     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/49.2.235     Document Type: Article

References (30)

1. Pseudomonas aeruginosa and the biofilm mode of growth
2. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: A mechanism for virulence activation in the cystic fibrosis lung
3. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
4. Testing antimicrobial susceptibilities of adherent bacteria by a method that incorporates guidelines of the National Committee for Clinical Laboratory Standards
5. Inhibition of tobramycin diffusion by binding to alginate
6. Establishment of aging biofilms: Possible mechanism of bacterial resistance to antimicrobial therapy
7. Chromosomal β-lactamase is packaged into membrane vesicles and secreted from Pseudomonas aeruginosa
8. 2
9. Antibiotic resistance of bacteria in biofilms
10. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone
11. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: A European consensus
12. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection
13. Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in vivo selection of stable partially derepressed β-lactamase producing strains
14. High-level β-lactamase activity in sputum samples from cystic fibrosis patients during antipseudomonal treatment
15. Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients
16. Polymyxin resistance and lipid A structure of Pseudomonas aeruginosa isolated from colistin-treated and colistin-naive cystic fibrosis patients
17. Oxidative stress in cystic fibrosis: Dietary and metabolic factors
18. Effect of oral N-acetylcysteine administration on human blood neutrophil and monocyte function
19. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis
20. Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin
21. Erythromycin inhibits the production of elastase by Pseudomonas aeruginosa without affecting its proliferation in vitro
22. Inhibition of Pseudomonas aeruginosa virulence factors by sub-inhibitory concentrations of azithromycin and other macrolide antibiotics
23. Airway biofilm disease: Its clinical manifestation and therapeutic possibilities of macrolides
24. Cationic antimicrobial peptides: Towards clinical applications
25. Specific phospholipids enhance the activity of β-lactam antibiotics against Pseudomonas aeruginosa
26. Alginate lyase promotes diffusion of aminoglycosides through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa
27. The efficacy of antibiotics enhanced by electrical currents against Pseudomonas aeruginosa biofilms
28. A prospective, randomized trial of long term azithromycin (AZM) versus placebo in cystic fibrosis: Impact on clinical, laboratory and quality of life (QOL) outcomes
29. Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa
30. How Delisea pulchra furanones affect quorum sensing and swarming motility in Serratia liquefaciens MG1